Seeing Is Believing
Currently out of the existing stock ratings of Kevin Caliendo, 151 are a BUY (49.51%), 11 are a SELL (3.61%), 143 are a HOLD (46.89%).
Analyst Kevin Caliendo, currently employed at UBS, carries an average stock price target met ratio of 60.97% that have a potential upside of 18.31% achieved within 238 days.
Kevin Caliendoās has documented 594 price targets and ratings displayed on 33 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on LH, Laboratory of America Holdings at 25-Jul-2025.
Analyst best performing recommendations are on AGTI (AGILITI).
The best stock recommendation documented was for AGTI (AGILITI) at 5/18/2021. The price target of $16 was fulfilled within 2 days with a profit of $0.81 (5.33%) receiving and performance score of 26.66.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$215
$40.04 (22.89%)
$187
1 years 11 months 27 days ago
(07-Aug-2023)
13/14 (92.86%)
$28.91 (15.54%)
633
Hold
$190
$15.04 (8.60%)
$176
2 years ago
(03-Aug-2023)
8/8 (100%)
$-0.86 (-0.45%)
433
Buy
$220
$45.04 (25.74%)
$213
2 years ago
(03-Aug-2023)
11/17 (64.71%)
$29.14 (15.27%)
326
Buy
$215
$40.04 (22.89%)
$200
2 years ago
(03-Aug-2023)
6/8 (75%)
$24.14 (12.65%)
220
Buy
$225
$50.04 (28.60%)
$184
2 years 2 days ago
(01-Aug-2023)
11/12 (91.67%)
$36.39 (19.29%)
557
Which stock is Kevin Caliendo is most bullish on?
Which stock is Kevin Caliendo is most reserved on?
What Year was the first public recommendation made by Kevin Caliendo?